评估Kaiser Permanente南加州地区初次人乳头瘤病毒筛查阳性女性阴道镜随访时间趋势
在Kaiser Permanente南加州地区2020年7月15日至2021年12月31日接受初次人乳头瘤病毒筛查、结果需阴道镜随访的30至65岁女性中,共纳入5833人,总体71%和78%分别在筛查结果后3个月和6个月内接受阴道镜。HPV 16/18阳性且细胞学正常低级别或高级别、以及其他高危HPV阳性且高级别细胞学的女性更可能在3个月内接受阴道镜,风险比范围为1.21至1.34。非西班牙裔黑人女性及最贫困社区女性在3个月内接受阴道镜的可能性较低。
要点
- 5833名女性中,71%在筛查后3个月内、78%在6个月内接受阴道镜。
- HPV 16/18阳性伴正常低级别或高级别细胞学、其他高危HPV伴高级别细胞学女性3个月内阴道镜风险比1.21至1.34。
- 非西班牙裔黑人女性(风险比0.93)和最贫困社区女性(风险比0.95)3个月内阴道镜可能性较低。
核心结论
- 观察结果证实了对HPV 16/18阳性及高级别细胞学结果女性诊断随访的优先安排。
- 阴道镜随访不完整及差异的障碍应被更好地理解和解决。
研究设计与样本
- 研究纳入2020年7月15日至2021年12月31日在Kaiser Permanente南加州地区接受初次人乳头瘤病毒筛查且结果需阴道镜随访的30至65岁女性,共5833人。
- 数据全部来自Kaiser Permanente南加州地区电子病历。
- 采用多变量改良泊松模型评估人乳头瘤病毒型别与分流细胞学结果、种族/民族、社区贫困指数与筛查结果后3个月和6个月内接受阴道镜之间的关联。
主要发现
- 纳入女性平均年龄42.9岁;亚裔/太平洋岛民、非西班牙裔黑人、西班牙裔和非西班牙裔白人分别占11.4%、9.8%、48.7%和24.4%。
- 总体71%和78%的女性分别在筛查结果后3个月和6个月内接受阴道镜。
- 与HPV非16/18其他高危型且低级别细胞学结果的女性相比,HPV 16/18阳性伴正常低级别或高级别细胞学结果的女性以及其他高危HPV伴高级别细胞学结果的女性在筛查结果后3个月内接受阴道镜的可能性更高,风险比范围为1.21(95%置信区间1.16-1.25)至1.34(95%置信区间1.25-1.42)。
- 非西班牙裔黑人女性(相较于非西班牙裔白人,风险比=0.93[0.87,1.00])和来自最贫困社区的女性(相较于最不贫困社区,风险比=0.95[0.90,1.00])在筛查后3个月内接受阴道镜的可能性较低。
- 6个月随访的发现与3个月相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Timeliness of colposcopy follow-up after primary human papillomavirus screening has not been well examined. OBJECTIVE: We evaluated time to colposcopy follow-up among women with an abnormal primary human papillomavirus screening result overall and by human papillomavirus genotype, triage cytology results, race/ethnicity, and neighborhood deprivation index. STUDY DESIGN: Women aged 30 to 65 years who received primary human papillomavirus screening at Kaiser Permanente Southern California from July 15, 2020, to December 31, 2021 and had screening results that required colposcopy follow-up were identified. All data were collected from Kaiser Permanente Southern California's electronic medical records. Multivariable modified Poisson models were used to evaluate the associations between human papillomavirus type and triage cytology results, race/ethnicity, neighborhood deprivation index, and receiving a colposcopy within 3 months and 6 months of screening results. RESULTS: A total of 5833 women were included. The mean age was 42.9 years; 11.4%, 9.8%, 48.7%, and 24.4% were of Asian/Pacific Islander, non-Hispanic Black, Hispanic, and non-Hispanic White race/ethnicity. Overall, 71% and 78% received colposcopy within 3 and 6 months of screening, respectively. Compared with women with non-16/18, other high-risk human papillomavirus types and low-grade cytology results, women with HPV 16/18 with normal low-grade or high-grade cytology results and women with other high-risk human papillomavirus and high-grade cytology results were more likely to have colposcopy within 3 months of screening results [risk ratio ranged from 1.21 (95% confidence interval, 1.16-1.25) to 1.34 (95% confidence interval, 1.25, 1.42)]. Non-Hispanic Black women (vs non-Hispanic White, risk ratio=0.93 [0.87, 1.00]) and women from the most deprived neighborhoods (vs least deprived, risk ratio=0.95 [0.90, 1.00]) had lower likelihoods of receiving colposcopy within 3 months of screening. Findings for 6 months of follow-up were similar to that of 3 months. CONCLUSION: Our observations confirmed prioritization of diagnostic follow-up for women with human papillomavirus 16/18+ as well as high-grade cytology results. Barriers to incomplete colposcopy follow-up and disparity should be better understood and addressed.
引用
- Habeshian TS, Xu L, Hahn EE, et al. Evaluating the trend of time to colposcopy follow-up among women with a positive primary human papillomavirus screening result at Kaiser Permanente Southern California. Am J Obstet Gynecol. 2025. PMID: 40157527. doi:10.1016/j.ajog.2025.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。